-
The Mechanism of Traditional Chinese Medicine and Natural Medicine in Treating Chronic Obstructive Pulmonary Disease
26 Apr 2025 05:08 GMT
… of TCM and modern medicine treatment strategies. The precise … Heme Oxygenase-1; IFN-γ, Interferon γ; IL, Interleukin; JNK, Jun … prevention. and Treatment of respiratory diseases. Pharmaceutical J Chin People … . Chin J New Drugs Clin Remedies. 2022;41(08): …
-
Annexin A: Cell Death, Inflammation, and Translational Medicine
26 Apr 2025 05:08 GMT
… clinically approved drugs (eg, sorafenib, sulfasalazine, statins, and … the development of pharmaceutical formulations, which … translational medicine approach to inflammatory disease treatment, which … al. ZBP1 mediates interferon-induced necroptosis. Cell …
-
CatalYm to Present New Data Demonstrating GDF-15 Blockade Enhances Efficacy of Antibody-Drug Conjugates at AACR 2025
25 Apr 2025 17:21 GMT
… -tumor activity of antibody-drug conjugates (ADCs). The … immune activity and enhances treatment efficacy, underscoring its potential … Phase 1/2a Trial; NCT04725474), that was recently … , proliferation and induction of interferon-γ.
About CatalYm
CatalYm is …
-
Harvard Built the Biotech Industry in Cambridge, Then Let It Go. Now It Wants Back In.
25 Apr 2025 10:18 GMT
… treating diabetes or alpha interferon for cancer treatment.
The recombination breakthrough, made … Biogen successfully developed their first drug — Avonex, used to treat multiple … of the biotech industry. Even as essential theoretical and medical research at …
-
New connective tissue cells could open path to pancreatic cancer treatment
24 Apr 2025 16:19 GMT
… responds poorly to traditional treatments with chemotherapy.
Researchers at … group, called ifCAF - interferon response cancer-associated fibroblasts, … proceeding to study potential drug substances that can promote … the development of future drugs.
About half a …
-
Measles Virus-Based Genetic Modifications: Progress in Hematological Malignancy Treatment
24 Apr 2025 16:10 GMT
… still experience relapse or drug resistance, resulting in …
Table 2 Clinical Trials of Treatment for Hematological Malignancies … models of glioblastoma. Nat Biotechnol. 2018. doi:10.1038 … Oncolytic measles viruses encoding interferon beta and the thyroidal …
-
Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Liver (EASL) Congress 2025
24 Apr 2025 13:57 GMT
… or in combination with pegylated interferon alfa (PEG-IFNα), in … clinical development for the treatment of patients with chronic … (siRNA) discovered by Alnylam Pharmaceuticals, Inc. It is designed … B.
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc., is a …
-
U.S. FDA Approves Second Drug Product Manufacturing Facility for ADSTILADRIN® (nadofaragene firadenovec-vncg)
24 Apr 2025 13:00 GMT
… Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA … ADSTILADRIN has transformed the treatment landscape for BCG-unresponsive … containing the gene interferon alfa-2b, administered … the Centers for Medicare and Medicaid Services (CMS), …
-
Rinvoq Shows Superior Remission Rates in Giant-Cell Arteritis With Reduced Steroid Use, Phase III Trial Finds
23 Apr 2025 17:18 GMT
… of Medicine.1,2 Currently, the only FDA-approved medication … treatments for this disease,” the study authors wrote. “[IL]-6 and interferon … of transcription.3 The drug is currently approved … according to the trial investigators. The trial’s key secondary …
-
Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025
23 Apr 2025 12:00 GMT
… Cancer: Developing Drugs and Biological Products for Treatment, Draft … in Japan by Chugai Pharmaceutical Co., Ltd. Protara … factor (TNF)-alpha, interferon (IFN)-gamma IL-6 … trials; statements related to expectations regarding interactions with the FDA …